Overview

A Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Docetaxel Consolidation in Patients With Inoperable Squamous Cell Lung Cancer

Status:
Unknown status

Trial end date:
2020-09-01

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy and toxicity of patients with inoperable squamous cell lung cancer treated with pemetrexed plus cisplatin with concurrent radiation therapy followed by docetaxel consolidation. An exploratory biomarker analysis in blood and tumor samples is also planned.

Phase:

Phase 2

Details

Lead Sponsor:

First People's Hospital of Hangzhou

Treatments:

Cisplatin
Docetaxel
Pemetrexed